PMID- 31941423 OWN - NLM STAT- MEDLINE DCOM- 20210907 LR - 20210907 IS - 1557-8577 (Electronic) IS - 1549-1684 (Linking) VI - 23 IP - 5 DP - 2020 Oct TI - Zengye Decoction Ameliorates Insulin Resistance by Promoting Glucose Uptake. PG - 367-376 LID - 10.1089/rej.2019.2228 [doi] AB - The incidence of type 2 diabetes mellitus (T2DM) has been increasing in recent years and has become a serious threat to human health. Zengye Decoction (ZYD), a well-known traditional Chinese medicinal formula, has been used in the treatment of T2DM with yin asthenia and extreme heat since Qing Dynasty. However, the characteristics of antidiabetic activities of ZYD have not been fully elucidated. In our study, high-fat diet and streptozotocin were used to establish the T2DM rat model. After 3 weeks of treatment with ZYD, the fasting blood glucose (FBG), oral glucose tolerance, the fasting serum insulin concentration, insulin sensitivity index (ISI), serum lipid profiles, and pancreas histopathology were measured. Then, under circumstance of insulin-resistant glucose consumption, 2-(N-(7-nitrobenz-2-oxa-l,3-diazol-4-yl) amino)-2-deoxyglucose (2-NBDG) uptake and glycogen content in C2C12 myotubes, 3T3-L1 adipocytes, and HepG2 cells were determined, respectively. Finally, the expressions of key targets in the insulin signaling pathway were measured to explain the potential mechanism underlying these activities. After administration with ZYD, a notable reduction in FBG levels, oral glucose tolerance test-area under the curve, blood lipid metabolism, and ISI values were observed compared with the diabetic control group. Moreover, ZYD restored the damaged islet cells in T2DM rats. Significant increases in glucose consumption, glucose uptake, glycogen content, expression of glucose transporter type 4, and the ratio of p-Akt/Akt were observed in the ZYD groups. According to the above results, ZYD exhibited glucose disposal, including glucose consumption, glucose uptake, and glycogen content and promoted the Akt signal pathway, which indicates that ZYD exerts significant hypoglycemic effect in T2DM. FAU - Wang, Mei AU - Wang M AD - Jiangsu Key Laboratory of TCM Evaluation and Translational Research, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, China. FAU - Chang, Shan-Quan AU - Chang SQ AD - Jiangsu Key Laboratory of TCM Evaluation and Translational Research, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, China. FAU - Tian, Yu-Shan AU - Tian YS AD - Jiangsu Key Laboratory of TCM Evaluation and Translational Research, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, China. FAU - Zhang, Ge-Qiang AU - Zhang GQ AD - School of Pharmacy, China Pharmaceutical University, Nanjing, China. FAU - Qi, Jin AU - Qi J AD - Jiangsu Key Laboratory of TCM Evaluation and Translational Research, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, China. AD - State Key Laboratory of Natural Medicines, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, China. LA - eng PT - Journal Article DEP - 20200415 PL - United States TA - Rejuvenation Res JT - Rejuvenation research JID - 101213381 RN - 0 (Blood Glucose) RN - 0 (Drugs, Chinese Herbal) RN - 0 (Insulin) RN - IY9XDZ35W2 (Glucose) SB - IM MH - Animals MH - Blood Glucose MH - *Diabetes Mellitus, Type 2/drug therapy MH - *Drugs, Chinese Herbal/therapeutic use MH - Glucose MH - Insulin MH - *Insulin Resistance MH - Rats OTO - NOTNLM OT - Akt OT - GLUT4 OT - Zengye Decoction OT - antidiabetic OT - glucose metabolism EDAT- 2020/01/17 06:00 MHDA- 2021/09/08 06:00 CRDT- 2020/01/17 06:00 PHST- 2020/01/17 06:00 [pubmed] PHST- 2021/09/08 06:00 [medline] PHST- 2020/01/17 06:00 [entrez] AID - 10.1089/rej.2019.2228 [doi] PST - ppublish SO - Rejuvenation Res. 2020 Oct;23(5):367-376. doi: 10.1089/rej.2019.2228. Epub 2020 Apr 15.